Medicine
Buprenorphine 2 mg sublingual tablet
Buprenorphine 2 mg sublingual tablet is a generic prescription medicine for sublingual use, made by 17 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Store Buprenorphine Sublingual Tablets…
Key facts
- Active ingredient (INN)
- Buprenorphine
- Brand
- Sold under the generic name
- Strength
- 2 mg
- Dosage form
- Sublingual tablet
- Route
- Sublingual
- Packs
- 30 tablets, 3 blister pack, 90 tablets and 32 more
- Manufacturers
- Sun Pharmaceutical IndustriesIndiaCamber PharmaceuticalsIndiaBryant Ranch PrepackRemedyrepackClinical Solutions WholesaleDirect_RxAdvagen PharmaActavis PharmaAmerican Health PackagingAvPAK
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Store Buprenorphine Sublingual Tablets securely and dispose of properly.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CIII
- ATC code
- N02AE01 Buprenorphine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 October 2009
- Identifiers
- RxCUI 351264, 351265, 2747481 +1DailyMed set ID 8d38f7aa-da0b-40ad-b0d1-4284c71042ed, 301eaed5-8499-ad95-e063-6294a90a58f5, a7da638f-f590-4577-bff9-15a91c6e7917 +21NDC 60687-481, 67296-2123, 71335-0950 +21Application ANDA207276, ANDA078633, ANDA201760 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 31722-870-30 | Camber PharmaceuticalsIndia | 12 January 2026 |
| 3 blister pack in 1 carton / 10 tablet in 1 blister pack | 62756-459-64 | Sun Pharmaceutical IndustriesIndia | 17 February 2016 |
| 30 tablet in 1 bottle | 62756-459-83 | Sun Pharmaceutical IndustriesIndia | 17 February 2016 |
| 30 tablet in 1 bottle | 0228-3156-03 | Actavis Pharma | 10 April 2015 |
| 30 tablet in 1 bottle | 72888-182-30 | Advagen Pharma | 23 January 2024 |
| 90 tablet in 1 bottle | 72888-182-90 | Advagen Pharma | 23 January 2024 |
| 30 tablet in 1 bottle | 0054-0176-13 | Hikma Pharmaceuticals | 8 October 2009 |
| 30 tablet in 1 bottle | 0121-1019-30 | PAI Pharma | 12 October 2023 |
| 30 tablet in 1 bottle | 42858-501-03 | Rhodes Pharmaceuticals | 25 October 2017 |
| 30 tablet in 1 bottle | 0406-7012-03 | SpecGx | 19 January 2026 |
| 30 tablet in 1 bottle | 63629-9475-1 | Bryant Ranch Prepack | 28 November 2022 |
| 60 tablet in 1 bottle | 71335-0950-1 | Bryant Ranch Prepack | 13 September 2018 |
| 90 tablet in 1 bottle | 71335-0950-2 | Bryant Ranch Prepack | 13 September 2018 |
| 30 tablet in 1 bottle | 71335-0950-3 | Bryant Ranch Prepack | 23 September 2022 |
| 7 tablet in 1 bottle | 71335-0950-4 | Bryant Ranch Prepack | 23 September 2022 |
| 28 tablet in 1 bottle | 71335-0950-5 | Bryant Ranch Prepack | 23 September 2022 |
| 1 tablet in 1 bottle | 71335-0950-6 | Bryant Ranch Prepack | 23 September 2022 |
| 12 tablet in 1 bottle | 71335-0950-7 | Bryant Ranch Prepack | 23 September 2022 |
| 120 tablet in 1 bottle | 71335-0950-8 | Bryant Ranch Prepack | 23 September 2022 |
| 30 tablet in 1 bottle | 72162-1344-3 | Bryant Ranch Prepack | 3 April 2026 |
| 30 tablet in 1 blister pack | 58118-0176-8 | Clinical Solutions Wholesale | 15 October 2018 |
| 30 tablet in 1 blister pack | 58118-0501-8 | Clinical Solutions Wholesale | 25 October 2017 |
| 30 tablet in 1 blister pack | 58118-4459-8 | Clinical Solutions Wholesale | 17 February 2025 |
| 50 pouch in 1 box / 1 tablet in 1 pouch | 70518-1557-1 | Remedyrepack | 7 July 2026 |
| 30 tablet in 1 blister pack | 70518-2226-0 | Remedyrepack | 19 July 2019 |
| 100 pouch in 1 box / 1 tablet in 1 pouch | 70518-2226-5 | Remedyrepack | 13 July 2026 |
| 30 pouch in 1 box / 1 tablet in 1 pouch | 70518-4570-0 | Remedyrepack | 10 February 2026 |
| 60 tablet in 1 bottle | 72189-579-60 | Direct_rx | 13 September 2024 |
| 60 tablet in 1 bottle | 72189-580-60 | Direct_Rx | 16 September 2024 |
| 90 tablet in 1 bottle | 72189-580-90 | Direct_Rx | 16 September 2024 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 60687-481-21 | American Health Packaging | 6 February 2020 |
| 50 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-128-15 | AvPAK | 19 March 2024 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-7154-04 | Major Pharmaceuticals | 8 October 2009 |
| 30 tablet in 1 bottle | 67296-2123-3 | Redpharm Drug | 8 October 2009 |
| 30 tablet in 1 blister pack | 87441-011-01 | Unit Dose Solutions | 17 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Buprenorphine
Clinical summary
Buprenorphine is a partial opioid agonist indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids, among other approved uses. MedsAcross supplies Buprenorphine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BuprenorphineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Buprenorphine prescribing information (Rhodes Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Buprenorphine Neuraxpharm: European public assessment report (EPAR) · European Medicines Agency
- Buvidal: European public assessment report (EPAR) · European Medicines Agency
Need Buprenorphine 2 mg sublingual tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.